Contact Lenses/Eye Wear News

The AAO announced its decision to host this year’s meeting, renamed Academy 2020 At Home, on an online platform.

CooperVision expanded its efforts in addressing myopia through the acquisition of C&E GP Specialists Inc., the company announced in a press release.

Analysis of the MiSight 1-day trial compared with clinical practice results showed an effective change in the natural history of myopia with a reduction in the proportion of fast progressors among both younger and older wearers.

Soft contact lens wear resulted in similar rates of microbial keratitis and other inflammatory adverse events in children first fit between ages 8 and 12 years compared with adults.

The majority of eye care providers consider myopia to be one of the biggest problems affecting children’s eyesight; however, only standard vision correction is offered for most of these patients.

2020 was supposed to be the year of vision, which we approached with great excitement. Never in our wildest dreams did we expect to face what we’re experiencing now. And who knows what the future will bring?

A greater need for treatment and awareness of visual impairment issues such as myopia among the population in East Asian countries exists, according to findings published in the British Journal of Ophthalmology.

Visual snow syndrome is a fascinating phenomenon of unknown neurological etiology. Although many clinicians have never even heard of it or consider it rare, my experience suggests it is more common than previously thought.

Executives from SightGlass Vision, developers of novel spectacles designed to slow myopia progression in children, are hoping this treatment option can help address the increasing prevalence of this condition worldwide.

NuEyes has partnered with ThirdEye to introduce the Pro 2 lightweight X2 MR Glasses for patients who have experienced visual impairment uncorrectable by traditional methods.